Utah pharmacy CEO accused of mislabeling hydroxychloroquine

Utah pharmacy CEO accused of mislabeling hydroxychloroquine

SALT LAKE CITY (AP) — The owner and CEO of a Utah pharmacy has been accused of mislabeling large amounts of malaria drugs imported from China that outgoing President Donald Trump incorrectly touted last year as a “miracle” treatment for the coronavirus. Dan Richards, the operator of Meds In Motion, was charged Monday with a misdemeanor for receiving large amounts of chloroquine and hydroxychloroquine from an unregistered manufacturer in China that were incorrectly labeled as Boswellia serrata extract, an herbal supplement. Richards’ attorney, Greg Skordas, says his client was trying to help state leaders who thought the drug could be a good treatment for the virus.